GENZYME CORPORATION for GENZYME CORPORATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 515, Patent Reform Act of 2009 H.R. 1260, Patent Reform Act of 2009 S. 610, Patent Reform Act of 2009 S. 3677 Financial Services and General Appropriations Act 2011 (Patent Settlement Provisions)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARA FROELICH | Vice President |
| KATHLEEN HOLCOMBE | Senior Policy Advisor |
| MARY MCGRANE | Senior Vice President |
Taxation/Internal Revenue Code TAX
H.R. 3156, Neglected Disease Tax Credit Bill Excise Tax for Medical Devices P.L. 111-148, Patient Protection & Affordable Health Care Act Excise Tax for Drugs and Biologics P.L. 111-152, Health Care and Education Reconciliation Act of 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARA FROELICH | Vice President |
| KATHLEEN HOLCOMBE | Senior Policy Advisor |
| MARY MCGRANE | Senior Vice President |
Medicare/Medicaid MMM
H.R. 444, 340B Program Improvement and Integrity Act of 2009, 340B drug price expansion ESRD "Bundling Issues" and ESRD Drug Reimbursement Issues HCPCS Coding Decisions Reimbursement for Part B Drugs Administered in Hospital Out-patient Departments, Dialysis Centers and Physician Offices Physician Fee Schedule Payment Rates for Lab Tests Medicaid Rebates Implementation of MIPPA H.R. 1699, Patient Access to Critical Lab Test H.R. 1452, Medicare Clinical Diagnostic Laboratory Fee Schedule Modernization Act of 2009 Reimbursement /Payment Laboratory Tests H.R. 676, US National Health Care Act or the Expanded and Improved Medicare for All Act Reimbursement for Clinical Lab Tests Reimbursement for Medicare Part D Drugs P.L. 111-148, Patient Protection & Affordable Health Care Act P.L. 111-152, Health Care and Education Reconciliation Act of 2010 S. 11, To Restore the Application of the 340B Drug Discount Program to Orphan Drugs with Respect to Children's Hospitals S. Amendment (Baucus) to H.R. 4848, Small Business and Infrastructure Jobs Tax Act of 2010 (340B Provisions) H.R. 1586, Education Jobs and Medicaid Funding Bill (AMP Revisions) H.R. 4899, Supplemental Appropriations Act 2010 (AMP Revisions) H.R.5712, Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Children's Hospitals Provision) Health Care Reform Implementation Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARA FROELICH | Vice President |
| KATHLEEN HOLCOMBE | Senior Policy Advisor |
| MARY MCGRANE | Senior Vice President |
Budget/Appropriations BUD
P.L. 111-152, Health Care and Education Reconciliation Act of 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARA FROELICH | Vice President |
| KATHLEEN HOLCOMBE | Senior Policy Advisor |
| MARY MCGRANE | Senior Vice President |
Pharmacy PHA
H.R. 3156, Neglected Disease Tax Credit Bill H.R. 759, Food and Drug Administration Globalization Act of 2009 P.L. 111-148, Patient Protection & Affordable Health Care Act Treatment of Orphan Drugs Under 340B Expansion P.L. 111-152, Health Care and Education Reconciliation Act of 2010 H.R. 3081, Continuing Appropriations Act of 2011 (340B Provisions)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARA FROELICH | Vice President |
| KATHLEEN HOLCOMBE | Senior Policy Advisor |
| MARY MCGRANE | Senior Vice President |
Medical/Disease Research/Clinical Labs MED
H.R. 1452, Medicare Clinical Diagnostic Laboratory Fee Schedule Modernization Act of 2009 Reimbursement for Clinical Lab Services under Medicare Excise Tax for Laboratory Services P.L. 111-148, Patient Protection & Affordable Health Care Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARA FROELICH | Vice President |
| KATHLEEN HOLCOMBE | Senior Policy Advisor |
| MARY MCGRANE | Senior Vice President |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.